To investigate the non inferiority of a short lasting antibiotic treatment (3 days) when compared to a long lasting antibiotic treatment (8 days), at Day 15 after the beginning of treatment in terms of clinical efficacy, in adults admitted to emergency services for a non severe Community Acquired Pneumonia (PAC), who responded well to 3 days of beta-lactamin treatment (3GC or A/AC).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
310
at Day 0, Day 30 and relapse
2 tablets 3 times a day for 5 days from Day 3
CH Argenteuil
Argenteuil, France
ACTIVE_NOT_RECRUITINGCHU Ambroise Paré
Boulogne-Billancourt, France
clinical evaluation at Day 15
Clinical evaluation at Day 15 composed of the composite measure of the Clinical examination for clinical symptoms of CAP, recording of the body temperature and confirmation that no additionnal antibiotic treatment was required from Day 8
Time frame: Day 15
clinical evaluation at Day 30
Clinical evaluation at Day 30 composed of the composite measure of the Clinical examination for clinical symptoms of CAP, recording of the body temperature and Evaluation of replapse or aggravation of pneumonia or any other respiratory infections in subjects considered cured at Day 15.
Time frame: Day 30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
2 tablets 3 times a day for 5 days from Day 3
administered from Day 0 to Day 3
CH Beaujon
Clichy, France
RECRUITINGCHI Creteil
Créteil, France
RECRUITINGCentral Hospital Raymon Poincaré
Garches, France
RECRUITINGCHU de Grenoble
La Tronche, France
RECRUITINGCH Versailles
Le Chesnay, France
ACTIVE_NOT_RECRUITINGCH Bicêtre
Le Kremlin Bicètre, France
RECRUITINGMelun Hospital
Melun, France
RECRUITINGCH d'Annecy Genevois
Metz-Tessy, France
ACTIVE_NOT_RECRUITING...and 10 more locations